Oyster peptide composition capable of improving sexual function of male and preparation method thereof

A technology of oyster peptide and composition, applied in the field of oyster peptide composition for improving male sexual function and its preparation field, can solve the problems of increased miscarriage and congenital defect rate, decreased survival rate of pups, poor reproductive function, etc. Effects of sexual dysfunction, reduction of prostate disease, ease of industrial production

Pending Publication Date: 2019-11-26
北京姿美堂生物技术股份有限公司
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It has been confirmed by data that when the content of taurine in animal feed is lower than 0.101%, its reproductive function is poor, the rate of stillbirth, abortion and congenital defects increases, and the survival rate of cubs decreases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oyster peptide composition capable of improving sexual function of male and preparation method thereof
  • Oyster peptide composition capable of improving sexual function of male and preparation method thereof
  • Oyster peptide composition capable of improving sexual function of male and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Embodiment 1 improves premature ejaculation test

[0038] (1) Volunteer selection criteria

[0039] ① The patient is a male aged 18 to 50 years.

[0040] ② Maintain a single and stable sexual relationship with the same woman for at least 6 months.

[0041] ③Conform to the diagnostic criteria for PE in the "Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition" promulgated by the American Psychiatric Association.

[0042] (2) Treatment plan

[0043] Treatment group: Tablets prepared in Example 4 of the composition of the present invention, 55 cases in total.

[0044] Control group: Vigorous Oyster Tablets group, a total of 55 cases.

[0045] (3) How to use

[0046] Both groups are taken orally, and used half an hour before sexual intercourse, and combined use is prohibited. The treatment group took 2 tablets twice a day for 4 consecutive weeks; the control group used it according to the instructions. The frequency of sex life is required to be once ...

Embodiment 2

[0054] Embodiment 2 improves erectile dysfunction

[0055] The 100 patients were all outpatients in the hospital. The oldest age was 63 years old, and the youngest age was 27 years old. Among them, 23 cases were 27-30 years old, 50 cases were 31-40 years old; 21 cases were 41-50 years old, and 6 cases were over 51 years old. The shortest is 1 month and the longest is 12 years. The selection criteria of patients were formulated according to the first volume of "Guiding Principles for Clinical Research of New Chinese Medicines" (1993). The main clinical manifestation of the patient is male sexual dysfunction.

[0056] 2. Diagnostic criteria: the penis cannot get erection or the erection is not firm, and the person who cannot complete sexual intercourse.

[0057] 3. Treatment method

[0058] All patients are administered capsules prepared according to the formula in Example 4 of the present invention, each 4 tablets, three times a day, taken with warm water; 2 weeks is 1 cours...

Embodiment 3

[0069] Embodiment 3 improves sperm motility test

[0070] 1. Test equipment and reagents

[0071] Cyclophosphamide was purchased from Jiangsu Hengrui Medicine Co., Ltd.; testosterone (T) radioimmunoassay kit, mouse follicle-stimulating hormone (FSH) radioimmunoassay kit, mouse luteinizing hormone (LH) radioimmunoassay kit , were purchased from Atom High Technology Co., Ltd.

[0072] 2. Experimental method

[0073] 2.1 Research object

[0074] Thirty clean-grade male SD rats were randomly divided into control group (intraperitoneal injection of purified water), model group (intraperitoneal injection of cyclophosphamide), and test group with 10 rats in each group. The oligospermia model was made by intraperitoneal injection of cyclophosphamide.

[0075] 2.2 Experimental method

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an oyster peptide composition capable of improving a sexual function of a male and a preparation method thereof. The composition is prepared from the following raw materials inparts by weight: 1 percent to 35 percent of oyster peptide powder, 1 percent to 30 percent of holothurian peptide powder, 1 percent to 25 percent of silkworm pupa extract, 1 percent to 25 percent oflepidium meyenii powder, 1 percent to 20 percent of eucommia ulmoides male pollen, 1 percent to 15 percent of raspberry powder, 1 percent to 15 percent of radix ginseng powder, 0.5 percent to 10 percent of taurine, 0.1 percent to 10 percent of L-arginine, and the balance of auxiliaries. The composition can be made into dosage forms including tablets, granules, capsules, soft capsules, powder or oral liquid. The composition disclosed by the invention has the advantages that the symptoms such as sexual dysfunction and prospermia of the male can be effectively improved, the intercourse duration is extended, the sexual function of the male is improved, the prostate disease is reduced, the activity of sperms is improved, and the infertility is improved.

Description

technical field [0001] The invention belongs to the technical field of health food, and in particular relates to an oyster peptide composition for improving male sexual function and a preparation method thereof. Background technique [0002] Male sexual activity is a complex physiological process, which must be completed through a series of conditioned reflexes and unconditioned reflexes. Sexual activities include sexual desire, penile erection, sexual intercourse, ejaculation, and orgasm. When any link occurs and affects normal sexual function, it is called male sexual dysfunction. Common male sexual dysfunction mainly manifests as impotence, ejaculation dysfunction, premature ejaculation, weak ejaculation, etc. directly affect fertility problems. [0003] Modern medical research uses methods such as moderately dilating blood vessels, increasing blood flow, activating cavernous body dynamics, significantly improving erection hardness, reducing sensitivity, prolonging erec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/01A61P15/00A61P15/10A61P13/08A61P15/08C12P21/06C07K1/34A23L19/00A23L21/20A23L33/10A23L33/175A23L33/18A61K35/64A61K31/185A61K31/198
CPCA23V2002/00A61K31/185A61K31/198A61K35/64A61K36/258A61K36/31A61K36/46A61K36/73A61K38/012A23L19/01A23L21/20A23L33/10A23L33/175A23L33/18A61P13/08A61P15/00A61P15/08A61P15/10C07K1/34C12P21/06A61K2300/00A23V2200/30A23V2250/0606A23V2250/0644A23V2250/1628A23V2250/204A23V2250/55A23V2250/612A23V2300/10A23V2300/14A23V2300/50A23V2250/032A23V2250/264
Inventor 徐熙明宫建辉
Owner 北京姿美堂生物技术股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products